Renal Replacement Therapy

Table 3 Comparison of Uno’s C-statistics for each endpoint

From: Usefulness of glycated albumin as a predictor of mortality in chronic hemodialysis patients with diabetes: a multi-center, prospective cohort study

Model 1	Original factors	Original factors + GA	Original factors + HbA1c
All-causes	0.718 (0.024)	0.718 (0.020)	0.720 (0.019)
p value^✻		0.963	0.655
p value^✻✻			0.638
ASCVD	0.806 (0.049)	0.824 (0.055)	0.810 (0.053)
p value^✻		0.239	0.714
p value^✻✻			0.141
Non-ASCVD	0.728 (0.026)	0.730 (0.025)	0.735 (0.022)
p value^✻		0.622	0.264
p value^✻✻			0.279
Model 2	Original factors	Original factors + GA	Original factors + HbA1c
All-causes	0.718 (0.019)	0.718 (0.018)	0.718 (0.023)
p value^✻		0.871	0.993
p value^✻✻			0.921
ASCVD	0.806 (0.061)	0.817 (0.049)	0.809 (0.073)
p value^✻		0.464	0.794
p value^✻✻			0.430
Non-ASCVD	0.728 (0.027)	0.729 (0.023)	0.731 (0.026)
p value^✻		0.729	0.480
p value^✻✻			0.595

Model 1, in which the hazard ratios were estimated using baseline GA or HbA1c values; and model 2, which used mean values of GA or HbA1c during the follow-up period
ASCVD atherosclerotic cardiovascular disease, GA glycated albumin, HbA1c hemoglobin A1c
^✻vs Uno’s C-statistics of original factors; ^✻✻vs Uno’s C-statistics of original factors plus GA

Back to article page

ISSN: 2059-1381

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com